🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this first-in-human study is to evaluate the safety, tolerab...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2025-07-31
Trial ID
NCT07094113
Treatments Being Tested
The purpose of this study is to investigate the activity of panitumumab in ...
Status
Terminated
Location
Institute Jules Bordet
Start Date
2009-09
Trial ID
NCT00973193
Treatments Being Tested
For the first phase of this study (phase I), the purpose will be to find th...
Status
Completed
Location
BCCA - Vancouver Cancer Centre
Start Date
2012-09-06
Trial ID
NCT01591421
Treatments Being Tested
First line chemotherapy treatment regimens for metastatic colorectal cancer...
Status
Unknown
Location
Associació Catalana per la Recerca Oncològica i les Seves Implicacions Sanitaries i Socials
Start Date
2009-09
Trial ID
NCT01144195
Treatments Being Tested
The primary objective was to describe the pattern of use of panitumumab (Ve...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-10
Trial ID
NCT01732783
Treatments Being Tested
The main purpose of the study is to assess the safety of 89Zr-panitumumab a...
Status
Withdrawn
Location
Stanford University
Start Date
2021-03-26
Trial ID
NCT04833959
Treatments Being Tested
This is a multi-center, open-label, randomized, phase 2, two-arm clinical t...
Status
Completed
Location
Multiple Locations
Start Date
2006-11-01
Trial ID
NCT00418938
Treatments Being Tested
Colorectal cancer (CRC) is a significant and growing health burden in Hong ...
Status
Unknown
Location
Department of Clinical Oncology, Tuen Mun Hospital, Tuen Mun
Start Date
2019-01-01
Trial ID
NCT04232748
Treatments Being Tested
This study evaluates how well panitumumab-IRDye800 and 89Zr-panitumumab wor...
Status
Completed
Location
Stanford Cancer Institute Palo Alto
Start Date
2019-01-07
Trial ID
NCT03733210
Treatments Being Tested
This phase II trial tests whether panitumumab and pembrolizumab in combinat...
Status
Withdrawn
Location
M D Anderson Cancer Center
Start Date
2022-03-11
Trial ID
NCT05177796
Treatments Being Tested